LGC
GILD icon

Laurel Grove Capital’s Gilead Sciences GILD Stock Holding History

Laurel Grove Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$621K Buy
8,037
+282
+4% +$21.3K 0.31% 66
2018
Q2 		$549K Sell
7,755
-1,000
-11% -$70.6K 0.29% 76
2018
Q1 		$660K Sell
8,755
-250
-3% -$19.9K 0.35% 67
2017
Q4 		$645K Sell
9,005
-4,120
-31% -$313K 0.33% 71
2017
Q3 		$1.06M Buy
13,125
+375
+3% +$28.7K 0.55% 56
2017
Q2 		$902K Sell
12,750
-3,600
-22% -$240K 0.48% 57
2017
Q1 		$1.11M Buy
16,350
+700
+4% +$49.2K 0.59% 49
2016
Q4 		$1.12M Buy
15,650
+2,200
+16% +$164K 0.61% 48
2016
Q3 		$1.06M Sell
13,450
-600
-4% -$48.7K 0.61% 51
2016
Q2 		$1.17M Sell
14,050
-5,500
-28% -$488K 0.7% 45
2016
Q1 		$1.8M Buy
19,550
+4,750
+32% +$428K 1.02% 35
2015
Q4 		$1.5M Buy
14,800
+9,150
+162% +$952K 0.84% 44
2015
Q3 		$555K Buy
5,650
+2,550
+82% +$283K 0.32% 69
2015
Q2 		$363K Sell
3,100
-100
-3% -$10.9K 0.19% 87
2015
Q1 		$314K Buy
3,200
+500
+19% +$50.8K 0.17% 89
2014
Q4 		$255K Hold
2,700
– – 0.15% 86
2014
Q3 		$287K Sell
2,700
-100
-4% -$9.79K 0.16% 81
2014
Q2 		$232K Sell
2,800
-1,000
-26% -$77.8K 0.13% 85
2014
Q1 		$269K Buy
3,800
+800
+27% +$62.7K 0.16% 85
2013
Q4 		$225K Buy
+3,000
New +$209K 0.13% 89

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Laurel Grove Capital's GILD Position: Q3 2018 in Review

Laurel Grove Capital increased its Gilead Sciences (GILD) stake by 3.6% in Q3 2018, buying an estimated $21.3K and bringing the position to 8,037 shares worth $621K. The position accounts for 0.31% of the portfolio, ranked #66.

Laurel Grove Capital first reported a position in GILD in Q4 2013 and has held it in 20 quarters since. The position peaked at $1.8M in Q1 2016. 1,528 funds tracked by Wall St. Rank hold GILD as of Q3 2018.

  • Laurel Grove Capital held 8,037 shares of Gilead Sciences worth $621K as of Q3 2018.
  • Laurel Grove Capital bought 282 Gilead Sciences shares in Q3 2018, an estimated $21.3K.
  • Gilead Sciences made up 0.31% of Laurel Grove Capital's portfolio in Q3 2018, its #66 holding.
  • Laurel Grove Capital first reported a position in Gilead Sciences in Q4 2013 and has held it in 20 quarters since.
  • Laurel Grove Capital's Gilead Sciences position peaked at $1.8M in Q1 2016.
  • 1,528 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2018.

Based on Laurel Grove Capital's 13F filing for Q3 2018, filed 12 Oct 2018.